Chesapeake Urology Research Associates(9.3 mi away)Contact
+162 other location
benign prostatic hypertrophy
This study will assess the efficacy of vibegron compared with placebo in men with overactive
bladder (OAB) symptoms on pharmacological therapy for benign prostatic hyperplasia (BPH) as
defined by micturition and urgency episodes.
Clinical Study Identifier
Urovant Sciences GmbH
Last Modified on
17 December 2020
How clear was the trial content above?
Adding a note
Select a piece of text and start making personal notes.
If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.